Company Directory > Digital Health > Cognier Insights
Cognier Insights is a specialized technology solutions provider focusing on the intersection of Artificial Intelligence (AI), Machine Learning (ML), and Blockchain technology. The company develops decentralized platforms and advanced analytical tools designed to drive digital transformation across various sectors, with a specific strategic focus on healthcare, real estate, and supply chain management. In the healthcare and pharmaceutical context, Cognier Insights leverages its expertise in blockchain for secure data management and AI-driven facial recognition and visual analytics. Their solutions aim to enhance data transparency and operational efficiency, although they do not develop proprietary therapeutic candidates or maintain a clinical drug pipeline.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:-
Industry:Digital Health
Sub-Industry:Healthcare AI & Blockchain Solutions
SIZE & FINANCIALS
Employees:1-50
Revenue:<$1M
Founded:2017
Ownership:private
Status:operating
FUNDING
Stage:Seed
Total Raised:$0.02M
Investors:Bootstrapped/Private Founders
0
CORPORATE STRUCTURE
Key Partnerships:IIIT-Hyderabad (Incubation/Campus location context)
COMPETITION
Position:Niche Player
Competitors:Intechnica, Sia Partners, Eightco, Gaudiy
LEADERSHIP
Key Executives:
Subba Rao Palukuri - Director
Mahesh Babu Dharmavarapu - Director
Nagi Reddy B - Founder/CEO
Scientific Founders:Nagi Reddy B
Board Members:Ayisha Shaik (Director), Kommaddi Mahammad Rafi (Director)
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Cognier Insights and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Cognier Insights. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.